BRPI0511822A - derivados heterocìclicos para tratamento da hiperlipidemia e doença relacionadas - Google Patents
derivados heterocìclicos para tratamento da hiperlipidemia e doença relacionadasInfo
- Publication number
- BRPI0511822A BRPI0511822A BRPI0511822-0A BRPI0511822A BRPI0511822A BR PI0511822 A BRPI0511822 A BR PI0511822A BR PI0511822 A BRPI0511822 A BR PI0511822A BR PI0511822 A BRPI0511822 A BR PI0511822A
- Authority
- BR
- Brazil
- Prior art keywords
- hyperlipidemia
- treatment
- related disease
- heterocyclic derivatives
- heterocyclic
- Prior art date
Links
- 208000031226 Hyperlipidaemia Diseases 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 125000000623 heterocyclic group Chemical group 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
- C07D231/40—Acylated on said nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Quinoline Compounds (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57822704P | 2004-06-09 | 2004-06-09 | |
| PCT/US2005/020660 WO2005123686A1 (en) | 2004-06-09 | 2005-06-09 | Heterocyclic derivatives for treatment of hyperlipidemia and related diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0511822A true BRPI0511822A (pt) | 2007-12-26 |
Family
ID=34981590
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0511822-0A BRPI0511822A (pt) | 2004-06-09 | 2005-06-09 | derivados heterocìclicos para tratamento da hiperlipidemia e doença relacionadas |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20060009487A1 (pt) |
| EP (1) | EP1753724A1 (pt) |
| JP (1) | JP2008502736A (pt) |
| KR (1) | KR20070026598A (pt) |
| CN (1) | CN1968928A (pt) |
| AR (1) | AR049216A1 (pt) |
| AU (1) | AU2005255011A1 (pt) |
| BR (1) | BRPI0511822A (pt) |
| CA (1) | CA2568394A1 (pt) |
| IL (1) | IL179210A0 (pt) |
| MX (1) | MXJL06000069A (pt) |
| NO (1) | NO20070139L (pt) |
| PE (1) | PE20050986A1 (pt) |
| RU (1) | RU2006145961A (pt) |
| TW (1) | TW200602042A (pt) |
| UY (1) | UY28953A1 (pt) |
| WO (1) | WO2005123686A1 (pt) |
| ZA (1) | ZA200700156B (pt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3965319B2 (ja) * | 2001-03-08 | 2007-08-29 | ザ ユニヴァーシティ オブ ホンコン | 有機金属発光材料 |
| EP1753782A1 (en) * | 2004-06-09 | 2007-02-21 | Avanir Pharmaceuticals | Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia |
| WO2006085685A1 (ja) * | 2005-02-09 | 2006-08-17 | Takeda Pharmaceutical Company Limited | ピラゾール化合物 |
| GB0619611D0 (en) * | 2006-10-04 | 2006-11-15 | Ark Therapeutics Ltd | Compounds and their use |
| DE102009036604A1 (de) | 2009-07-30 | 2011-02-03 | Aicuris Gmbh & Co. Kg | Substituierte Bis-Arylpyrazolamide mit terminaler primärer Amidfunktionalisierung und ihre Verwendung |
| CA2792068A1 (en) | 2010-04-02 | 2011-10-06 | Senomyx, Inc. | Sweet flavor modifier |
| MX336378B (es) | 2011-08-12 | 2016-01-15 | Senomyx Inc | Modificador del sabor dulce. |
| CN103497151B (zh) * | 2013-10-30 | 2015-07-15 | 山东铂源药业有限公司 | 一种4-氨基-6-甲基烟酸的合成方法 |
| CA2963901A1 (en) | 2014-11-07 | 2016-05-12 | Senomyx, Inc. | Substituted 4-amino-5-(cyclohexyloxy)quinoline-3-carboxylic acids as sweet flavor modifiers |
| CN106187887B (zh) * | 2016-07-01 | 2018-08-14 | 上海工程技术大学 | 4-羟基喹啉-3-甲酸的制备方法 |
| JP7013446B2 (ja) * | 2016-08-16 | 2022-02-15 | ユーダブリューエム・リサーチ・ファウンデーション，インコーポレーテッド | Ｇａｂａ（ａ）受容体モジュレーター、及び、喘息における気道過敏及び炎症を抑制するための方法 |
| CN108623561B (zh) * | 2017-03-24 | 2025-04-01 | 中国海洋大学 | 一种制备哌尼诺酸化合物的方法 |
| CN108456154A (zh) * | 2018-04-13 | 2018-08-28 | 昆明理工大学 | 一种n-叔丁氧羰基烃基胍的制备方法 |
| SG11202107614PA (en) * | 2019-01-18 | 2021-08-30 | Astrazeneca Ab | Pcsk9 inhibitors and methods of use thereof |
| AU2020209216A1 (en) | 2019-01-18 | 2021-08-26 | Astrazeneca Ab | PCSK9 inhibitors and methods of use thereof |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773946A (en) * | 1969-09-02 | 1973-11-20 | Parke Davis & Co | Triglyceride-lowering compositions and methods |
| US3930024A (en) * | 1969-09-02 | 1975-12-30 | Parke Davis & Co | Pharmaceutical compositions and methods |
| JPS5522636A (en) * | 1978-08-04 | 1980-02-18 | Takeda Chem Ind Ltd | Thiazoliding derivative |
| IL64542A0 (en) * | 1981-12-15 | 1982-03-31 | Yissum Res Dev Co | Long-chain alpha,omega-dicarboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| JPS60136512A (ja) * | 1983-12-26 | 1985-07-20 | Eisai Co Ltd | 脂質代謝改善剤 |
| DE3423166A1 (de) * | 1984-06-22 | 1986-01-02 | Epis S.A., Zug | Alpha-, omega-dicarbonsaeuren, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten |
| US5648387A (en) * | 1995-03-24 | 1997-07-15 | Warner-Lambert Company | Carboxyalkylethers, formulations, and treatment of vascular diseases |
| JPH10316641A (ja) * | 1997-03-14 | 1998-12-02 | Sankyo Co Ltd | カルボン酸誘導体 |
| WO1999003880A1 (en) * | 1997-07-15 | 1999-01-28 | Novo Nordisk A/S | Nociceptin analogues |
| US6004925A (en) * | 1997-09-29 | 1999-12-21 | J. L. Dasseux | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| MXPA01009893A (es) * | 1999-04-01 | 2003-07-28 | Esperion Therapeutics Inc | Compuestos con eter, composiciones y usos de estos. |
| US7148197B2 (en) * | 2000-08-24 | 2006-12-12 | The Regents Of The University Of California | Orally administered small peptides synergize statin activity |
| US6664230B1 (en) * | 2000-08-24 | 2003-12-16 | The Regents Of The University Of California | Orally administered peptides to ameliorate atherosclerosis |
| FR2820435B1 (fr) * | 2001-02-05 | 2004-02-27 | Genfit S A | Procedes d'identification de composes modulant le transport inverse du cholesterol |
| US20040248950A1 (en) * | 2001-08-24 | 2004-12-09 | Natsuki Ishizuka | Apo ai expression accelerating agent |
| US7429593B2 (en) * | 2001-09-14 | 2008-09-30 | Shionogi & Co., Ltd. | Utilities of amide compounds |
| KR20050114283A (ko) * | 2003-04-22 | 2005-12-05 | 아바니르 파마슈티컬스 | 고콜레스테롤혈증을 치료하기 위한 역 콜레스테롤 수송의매개제 |
-
2005
- 2005-06-09 MX MXJL06000069A patent/MXJL06000069A/es not_active Application Discontinuation
- 2005-06-09 RU RU2006145961/04A patent/RU2006145961A/ru not_active Application Discontinuation
- 2005-06-09 JP JP2007527787A patent/JP2008502736A/ja not_active Withdrawn
- 2005-06-09 KR KR1020067026459A patent/KR20070026598A/ko not_active Withdrawn
- 2005-06-09 WO PCT/US2005/020660 patent/WO2005123686A1/en not_active Ceased
- 2005-06-09 EP EP05758578A patent/EP1753724A1/en not_active Withdrawn
- 2005-06-09 AR ARP050102363A patent/AR049216A1/es unknown
- 2005-06-09 TW TW094118999A patent/TW200602042A/zh unknown
- 2005-06-09 UY UY28953A patent/UY28953A1/es not_active Application Discontinuation
- 2005-06-09 BR BRPI0511822-0A patent/BRPI0511822A/pt not_active Application Discontinuation
- 2005-06-09 US US11/149,067 patent/US20060009487A1/en not_active Abandoned
- 2005-06-09 PE PE2005000658A patent/PE20050986A1/es not_active Application Discontinuation
- 2005-06-09 CN CNA2005800191718A patent/CN1968928A/zh active Pending
- 2005-06-09 CA CA002568394A patent/CA2568394A1/en not_active Abandoned
- 2005-06-09 AU AU2005255011A patent/AU2005255011A1/en not_active Abandoned
-
2006
- 2006-11-13 IL IL179210A patent/IL179210A0/en unknown
-
2007
- 2007-01-05 ZA ZA200700156A patent/ZA200700156B/en unknown
- 2007-01-08 NO NO20070139A patent/NO20070139L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1753724A1 (en) | 2007-02-21 |
| AR049216A1 (es) | 2006-07-05 |
| CN1968928A (zh) | 2007-05-23 |
| IL179210A0 (en) | 2007-03-08 |
| MXJL06000069A (es) | 2007-04-10 |
| KR20070026598A (ko) | 2007-03-08 |
| TW200602042A (en) | 2006-01-16 |
| NO20070139L (no) | 2007-03-08 |
| US20060009487A1 (en) | 2006-01-12 |
| JP2008502736A (ja) | 2008-01-31 |
| PE20050986A1 (es) | 2006-02-03 |
| WO2005123686A1 (en) | 2005-12-29 |
| ZA200700156B (en) | 2008-05-28 |
| CA2568394A1 (en) | 2005-12-29 |
| UY28953A1 (es) | 2006-01-31 |
| AU2005255011A1 (en) | 2005-12-29 |
| RU2006145961A (ru) | 2008-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2022001I1 (el) | Παραγωγα του uk-2a | |
| HUS1500034I1 (hu) | Indolidon-származékok fibrózisos betegségek kezelésére vagy megelõzésére | |
| DK1849773T3 (da) | Piperazinderivater til behandlingen af urininkontinens og smerte | |
| DK2049525T3 (da) | N-laminoheteroaryl)-1H-indol-2-carboxamid-derivater, og fremstilling og terapeutisk anvendelse deraf | |
| CY2014011I1 (el) | Χορηγηση αναστολεων διπεπτιδυλοπεπτιδασης | |
| PL1708991T3 (pl) | Pochodne sulfonoamidu do leczenia chorób | |
| CY2017048I2 (el) | Νεες φαρμακευτικες χρησεις των παραγωγων σταυροσπορινης | |
| BRPI0812361A2 (pt) | Derivados de pirazol heteroaril-substituídos úteis parao tratamento de distúrbios e doenças hiperproliferativos associados à angiogênese | |
| EE200500033A (et) | Latentse tuberkuloosi ravi | |
| DK1917246T3 (da) | Benzoquinazolinderivater og deres anvendelse til behandling af knoglesygdomme | |
| BRPI0511822A (pt) | derivados heterocìclicos para tratamento da hiperlipidemia e doença relacionadas | |
| DK1793855T4 (da) | Forebyggelse og behandling af synukleinopatisk og amyloidogenisk sygdom | |
| DK1708992T3 (da) | Sulfonamidderivater til behandling af sygdomme | |
| SI3424932T1 (sl) | Boronoftalidi za terapevtsko uporabo | |
| DK1706112T3 (da) | Fremgangsmåder til at behandle en inflammatorisk-beslægtet sygdom | |
| HUS1500058I1 (hu) | Benzoxazint tartalmazó gyógyszer-kombináció légúti betegségek kezelésére | |
| DK2026880T4 (da) | Farmaceutisk og kosmetisk brug af silica | |
| DK2007769T3 (da) | Dimerer af artemisininderivater, fremstilling deraf og terapeutisk anvendelse deraf | |
| BRPI0607198A2 (pt) | composição, uso da composição método de tratamento doenças, e, embalagem farmacêutica | |
| BRPI0818267A2 (pt) | Novos derivados de 1,3-dihidro-5-isobenzofuranocarbonitrila e composição farmacêutica dos mesmos para o tratamento de ejaculação precoce | |
| DK1968574T3 (da) | Anvendelse af benzokondenserede heterocykliske sulfamidderivater til behandling af obesitet | |
| ATE484279T1 (de) | Isosorbid-mononitrat-derivate zur behandlung von darmerkrankungen | |
| ATE420081T1 (de) | Trifluormethylbenzamidderivate und therapeutische verwendungen dafür | |
| CR8618A (es) | Nuevos derivados de bencil (dieno)-lactamas | |
| DK1828137T3 (da) | 4-Cycloalkyl-substituerede tetrahydroquinolinderivater og deres anvendelse som medikamenter |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |